Present: The published funding information is incomplete.
Correct: Additional funding information is given below.
Funding
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement nr 602856 (EEC) and nr 278742 (EUROSARC).
Original article: Oncotarget. 2015; 6:18875-90. doi: 10.18632/oncotarget.4303